Fluarix using different strains from those of other vaccines, GSK says

Published: 2004-10-28 07:00:00

Updated: 2004-10-28 07:00:00

GlaxoSmithKline said recently that its Fluarix, an influenza vaccine, is using different strains from those of other vaccines, in response to the controversial announcement of the Korea Food and Drug Administration and reports of some news media that all of influenza vaccine preparations marketed...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK